U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.1737del (p.Asn580fs) AND Marfan syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
May 10, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003447674.1

Allele description [Variation Report for NM_000138.5(FBN1):c.1737del (p.Asn580fs)]

NM_000138.5(FBN1):c.1737del (p.Asn580fs)

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.1737del (p.Asn580fs)
HGVS:
  • NC_000015.10:g.48508683del
  • NG_008805.2:g.142107del
  • NM_000138.5:c.1737delMANE SELECT
  • NM_001406716.1:c.1737del
  • NP_000129.3:p.Asn580Thrfs
  • NP_000129.3:p.Asn580fs
  • NP_001393645.1:p.Asn580fs
  • LRG_778t1:c.1736del
  • LRG_778:g.142107del
  • LRG_778p1:p.Asn580Thrfs
  • NC_000015.9:g.48800880del
  • NM_000138.4:c.1736delG
  • NM_000138.5:c.1737delGMANE SELECT
Protein change:
N580fs
Molecular consequence:
  • NM_000138.5:c.1737del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001406716.1:c.1737del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Marfan syndrome (MFS)
Synonyms:
MARFAN SYNDROME, TYPE I; Marfan syndrome type 1; Marfan's syndrome; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007947; MedGen: C0024796; Orphanet: 284963; Orphanet: 558; OMIM: 154700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004175225Genetics and Molecular Pathology, SA Pathology

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 10, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Genetics and Molecular Pathology, SA Pathology, SCV004175225.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The FBN1 c.1737del variant is classified as a LIKELY PATHOGENIC (PVS1, PM2) The variant is a single-base pair deletion in exon 15/66 of the FBN1 gene, which is predicted to result in a frameshift starting with codon Asparagine 580, changes this amino acid to a Threonine residue, and creates a premature STOP codon 45 amino acids downstream, denoted p.N580TfsX45. This variant is predicted to cause loss of normal protein function which is a known disease causing mehanism of Marfan syndrome in the FBN1 gene (PVS1). The variant is not in dbSNP and is absent from population databases (PM2). The variant has not been reported in ClinVar or HGMD.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 17, 2023